GreenLight Biosciences Welcomes Amin Khan As Chief Scientific Officer, Human Health
BOSTON, April 28, 2021 /PRNewswire/ GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design, and manufacturing for human, animal, and plant health, today announced the appointment of Amin Khan as the company s Chief Scientific Officer, Human Health.
Khan joins GreenLight from GSK s Vaccines business where he was a member of their R&D leadership team. He headed their Technical R&D organization, and recently led Vaccines R&D Acceleration, where he was responsible for end-to-end accelerated development of the vaccine portfolio. GreenLight aims to address humanity s greatest challenges, from producing vaccines to protecting bees, said Andrey Zarur, CEO of GreenLight Biosciences. Amin brings deep experience developing and launching vaccines, which will be critical to our mission to democratize healthcare.
GreenLight Biosciences Welcomes Amin Khan As Chief Scientific Officer, Human Health prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
GreenLight Biosciences Welcomes Mark Singleton As Lead For Plant Health Innovation
BOSTON, March 3, 2021 /PRNewswire/ GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design and manufacturing for human, animal and plant health, today announced the appointment of Mark Singleton as the company s Senior Vice President of Technology and External Innovation. GreenLight is working to address humanity s greatest challenges, from producing vaccines to protecting bees, said Andrey Zarur, CEO of GreenLight. Mark brings the experience and expertise we need to advance towards our goal of feeding the world s growing population while protecting the planet.
Singleton will report to Andrey Zarur and lead on plant health innovations such as GS2, GreenLight s RNA-based Colorado potato beetle control product.
GreenLight Biosciences Welcomes Mark Singleton As Lead For Plant Health Innovation prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Greenlight Biosciences Welcomes Thomas Crampton as Senior Vice President for Corporate Affairs
News provided by
Share this article
Share this article
BOSTON, Jan. 27, 2021 /PRNewswire/ GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design and manufacturing for human, animal and plant health, today announced the appointment of Thomas Crampton as the company s Senior Vice President for Corporate Affairs. Regulatory approvals last year moved RNA vaccines from the realm of scientific theory to medical reality and made them a core tool to combat the COVID-19 pandemic, said Charles Cooney, Chairman of GreenLight s board. Thomas brings the strategic experience, global outlook and leadership skills to scale GreenLight s ambition to match the transformative potential for RNA across life sciences, agriculture and beyond.